Company Filing History:
6 out of 712 
1 out of 2 
1 out of 2 Years Active: 2003-2023
Title: Roderick MacKinnon: A Pioneer in Pharmacological Innovation
Introduction
Roderick MacKinnon is a notable inventor based in New York, NY, whose contributions to the field of pharmacology and biochemistry have resulted in a remarkable eight patents. His innovative approach has significantly advanced our understanding and treatment approaches to human health, particularly in relation to cardiac functions and muscle dynamics.
Latest Patents
Two of his latest patents highlight his pioneering work. The first, titled "Engineered hERG channel proteins, vesicles and methods of identifying small molecule pharmacological agents," provides methods and compositions relating to an assay for hERG channel protein sensitivity. This invention features an engineered hERG channel protein and methods for identifying small molecule pharmacological agents that may interfere with the repolarization of cardiac cells. The second patent involves "Methods of treating muscle cramping and related compositions," which describes compositions comprising capsaicin and outlines methods for treating muscle cramping, specifically through oral administration of capsaicin-containing compositions.
Career Highlights
Throughout his career, Roderick MacKinnon has worked with prestigious institutions, including The Rockefeller University and Flex Pharma, Inc. His tenure at these organizations has allowed him to collaborate on cutting-edge research, pushing the boundaries of what is known in pharmacology.
Collaborations
Collaboration has been a significant aspect of MacKinnon's career. He has worked alongside talented individuals such as Alice Lee MacKinnon and Youxing Jiang, contributing to a rich exchange of ideas and fostering innovation in the research community.
Conclusion
Roderick MacKinnon's work continues to inspire future inventors and researchers in the fields of pharmacology and biochemistry. His dedication to advancing medical science through innovative patents demonstrates the critical impact that inventors can have on healthcare and treatment methodologies.